Krempa David bought ETON

May 26, 2026 · Form 4 insider transaction

Krempa David bought 25,000 shares of Eton Pharmaceuticals, Inc. at $1.38 per share, a transaction worth $34.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Acquired (buy-side)
Shares
25,000
Price
$1.38
Total value
$34.5K
Role
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMay 26, 2026
Filing dateMay 27, 2026
Shares owned after50,249
OwnershipDirect
10b5-1 planNo
AmendedNo
View the original Form 4 on SEC EDGAR